Jinyi Xu

Title: Innovations by Jinyi Xu in Pharmaceutical Chemistry

Introduction

Jinyi Xu is a notable inventor based in Taizhou, China, recognized for his contributions to pharmaceutical chemistry. He holds two patents that focus on the development of crystal forms of important pharmaceutical compounds. His work aims to enhance the quality and stability of medications, which is crucial in the field of drug development.

Latest Patents

Jinyi Xu's latest patents include the following:

1. **Crystal forms of bedaquiline fumarate and preparation methods therefor** - This patent provides crystal forms I, II, and III of bedaquiline fumarate, along with their preparation methods. The crystal forms exhibit high purity, excellent physicochemical properties, and good stability. The preparation methods outlined can significantly improve product quality and are suitable for the preparation and mass production of medicines.

2. **Crystal form of dabigatran etexilate mesylate and preparation method and use thereof** - This invention relates to novel crystal forms M and N of dabigatran etexilate mesylate. The patent details the characteristic peaks of the X-Ray powder diffractogram for both crystal forms, indicating their unique properties. These crystal forms demonstrate excellent performance in terms of leaching time, biological release, chemical stability, and processing adaptability.

Career Highlights

Jinyi Xu is currently employed at Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has contributed to advancements in drug formulation and stability, which are essential for effective medication delivery.

Collaborations

Jinyi Xu collaborates with several professionals in his field, including Liang Zhang and Jian Chai, who contribute to the research and development efforts at his company.

Conclusion

Jinyi Xu's innovative work in pharmaceutical chemistry, particularly in the development of crystal forms for medications, showcases his commitment to improving drug quality and stability. His contributions are significant in the ongoing efforts to enhance pharmaceutical formulations.